Neuro-Oncologyの進歩
Online ISSN : 2187-0551
Print ISSN : 1880-0742
ISSN-L : 1880-0742
グリオーマの免疫染色定量評価
高野 晋吾松田 真秀石川 栄一坂本 規影阿久津 博義木野 弘善山本 哲哉松村 明
著者情報
ジャーナル フリー

2016 年 23 巻 1 号 p. 14-20

詳細
抄録
For neuropathological diagnosis of glial tumors, molecular diagnosis is also important as well as classical histological diagnosis. Key molecules for glial tumors include mutations in isocitrate dehydrogenase (IDH) 1and 2, 1p/19q loss of heterozygocity (LOH), p53 mutation, ATRX mutation, MGMT promoter methylation, Tert promoter methylation as well as Ki67. Immunohistochemistry is simple, robust and universal detection methods for these mokecules compared to genetic analysis. We applied automatedquantitative analysis for detection of Ki67 index, p53 mutation and MGMT promoter methylation using Gunma-LI that were developed for Ki67 detection of brain tumors. Automated count (trial method) and manual count as a golden standard) of 18 samples of glioma sections were compared. We found automated analysis with Gunma-LI is useful for quantitative detection of p53 mutation and MGMT promoter methylation as well as Ki67 index.This method might be applied for individual molecular analysis instead of genetic examination in multicenter clinical trial.
著者関連情報
© 2016 近畿脳腫瘍病理検討会
前の記事 次の記事
feedback
Top